Month: June 2021

FLORHAM PARK, N.J., June 03, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced the protocol amendment to expand its Phase 2 VERSATILE-002 study to include patients, in an additional arm, who have failed prior checkpoint inhibitor (CPI) therapy (CPI refractory patients). The VERSATILE-002 study is designed to evaluate PDS0101 in combination with KEYTRUDA® (pembrolizumab) in the treatment of advanced human papillomavirus (HPV)-associated head and neck cancer and is currently being run at approximately 20 clinical sites in the US. VERSATILE-002 was initially opened to checkpoint inhibitor naive HPV16-associated head and...

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN HALIFAX, Nova Scotia, June 03, 2021 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or the “Company”), a home health care organization ranked #2 on the 2020 Report on Business ranking of Canada’s Top Growing Companies, is pleased to announce an increase in size of its non-brokered private placement of common shares (“Common Shares”) announced May 31, 2021. Due to oversubscribed demand, the non-brokered private placement of Common Shares will now consist of the issuance of up to 7,638,888 Common Shares at a price of CAD$0.72 per Common Share for maximum gross proceeds of CAD$5.5 million (the “Offering”).      The Offering is subject to certain conditions including,...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 03, 2021 (GLOBE NEWSWIRE) — International Consolidated Uranium Inc. (“CUR” or the “Company”) (TSXV: CUR) is pleased to announce that it has closed its previously announced “bought deal” private placement (the “Offering”) with Haywood Securities Inc. and Red Cloud Securities Inc. (the “Underwriters”) as co-lead underwriters. The Offering consisted of an aggregate of 5,000,400 units of the Company (the “Units”), including the full exercise of the Underwriters’ option, at a price of C$1.80 per Unit (the “Issue Price”) for aggregate gross proceeds of C$9,000,720. Philip Williams, President and CEO commented “We are pleased to close another over-subscribed financing, backed by strong institutional support,...

PRESS RELEASE SCHINDELLEGI, SWITZERLAND, JUNE 3, 2021   Trifork Holding AG is participating in the Carnegie IT services investor seminar in Copenhagen on June 3, 2021. You can find the presentation on the Trifork investor website https://investor.trifork.com/presentations/.   For further information, please contact: Dan Dysli, Head of Investor Relationsddy@trifork.com, +41 79 421 6299    

Agreement Marks Expansion into the Broad Acre Crops Market DAVIS, Calif., June 03, 2021 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI or “Marrone Bio”), an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, has entered into a partnership with ATP Nutrition of Manitoba, Canada to distribute Stargus Biofungicide on Canadian broad acre crops; primarily canola, dry beans, peas, soybeans and sunflower. These products represent more than 30 million acres in Canada where the biocontrol market is estimated to be growing at 12-15% CAGR.  “We are very pleased to partner with ATP Nutrition; a best-in-class distributor with strong market share and a respected reputation with Canadian farmers,” states Kevin Helash, chief executive officer of Marrone Bio Innovations....

DANBURY, Conn., June 03, 2021 (GLOBE NEWSWIRE) — FuelCell Energy (Nasdaq: FCEL) — a global leader in fuel cell technology — with a purpose of utilizing its proprietary, state-of-the-art fuel cell platforms to enable a world empowered by clean energy — today announced the upcoming release of its second quarter results prior to the Stock Market Open on Thursday, June 10, 2021. FuelCell Energy management will subsequently host a conference call with investors beginning at 10:00 a.m. Eastern Time on Thursday, June 10, 2021 to discuss the second quarter results for fiscal 2021. Participants can access the live call via webcast on the Company website or by telephone as follows:The live webcast of this call and supporting slide presentation will be available at www.fuelcellenergy.com.  To listen to the call, select...

Ms. Bell’s extensive experience serving as corporate director for multiple listed corporations will further strengthen the Board of mdf commerce to ensure the successful ongoing implementation of the Company’s strategic plan MONTREAL, June 03, 2021 (GLOBE NEWSWIRE) — mdf commerce inc. (TSX:MDF), a leader in SaaS commerce technology solutions, is proud to announce the appointment of Mary-Ann Bell, Ing., ASC, to its Board of Directors. Since 2012, Mary-Ann Bell has provided guidance to management teams on a variety of strategic topics such as digital transformation, cybersecurity, financial performance analysis, human resources planning and governance practices, among others. She currently serves as a corporate director of SNC-Lavalin, Cogeco, NAV CANADA and the Institute for Governance of Private and Public Organizations (IGOPP)....

ATLANTA, June 03, 2021 (GLOBE NEWSWIRE) — Paya Holdings Inc. (NASDAQ: PAYA) (“Paya”), a leading provider of integrated payment and commerce solutions, today announced that Jeff Hack, Paya CEO and other senior management are scheduled to participate in the following upcoming virtual investor conferences: Baird 2021 Global Consumer, Technology & Services ConferenceDate: Wednesday, June 9, 2021Presentation time: 11:25 am EDT Morgan Stanley US Financials, Payments & CRE Conference Date: Monday, June 14, 2021Presentation time: 9:30 am EDT The presentations will be webcast live, and replays will be available for a limited time under the “Events & Presentations” section on the Company’s investor relations website at investors.paya.com. About PayaPaya (NASDAQ: PAYA) is a leading provider of integrated payment and frictionless...

WDNA offers targeted exposure to companies that will be significantly transformed by advancements in genetics and biotechnology, including COVID-19 vaccines WisdomTree leveraged data and thematic insights from one of the world’s leading technology futurists Dr. Jamie Metzl NEW YORK, June 03, 2021 (GLOBE NEWSWIRE) — WisdomTree Investments, Inc. (NASDAQ: WETF), an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor and asset manager, announced today the launch of the WisdomTree BioRevolution Fund (WDNA) on the CBOE. WDNA seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (WTDNA), and has an expense ratio of 0.45%. “The biology revolution is creating a historic investment opportunity equivalent to the industrial and internet revolutions,” said Jeremy...

CAMBRIDGE, Mass., June 03, 2021 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted T cells directly within the patient’s body, announced today it will give a presentation at the 2021 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting, which is being held virtually from June 8-11, 2021. Anish Suri, president and chief scientific officer of Cue Biopharma, will discuss preclinical data on CUE-401, the Company’s most recent autoimmune drug product candidate. CUE-401, part of the CUE-400 series designed for differentiation and expansion of induced regulatory T cells (iTregs), is a bispecific molecule engineered to deliver the two signals, transforming growth factor beta...